# Evaluation of the Efficacy of OMK2 in Recovering Corneal Neural Damage in Patients With Diabetes

> **NCT03906513** · NA · COMPLETED · sponsor: **University of Milan** · enrollment: 30 (actual)

## Conditions studied

- Cornea

## Interventions

- **DEVICE:** OMK2

## Key facts

- **NCT ID:** NCT03906513
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-03
- **Primary completion:** 2017-05-03
- **Final completion:** 2019-01-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03906513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03906513, "Evaluation of the Efficacy of OMK2 in Recovering Corneal Neural Damage in Patients With Diabetes". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03906513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*